Tutti gli studi
Attivo ma non reclutanteNAINTERVENTISTICO

Cohort of Hospitalized Patients Suspected of Leptospirosis

This study, called COLEPT, is for people admitted to hospital because doctors think they might have leptospirosis. Leptospirosis is an infection caused by bacteria, often spread from animals, and it’s not very well understood. By following patients for a whole year, researchers hope to learn more about how the illness develops, how the body fights it, and how it affects people over time. This information will help doctors understand and treat leptospirosis better in the future. Taking part involves giving blood and urine samples occasionally, which will also be stored in a 'biobank' for future research. This study aims to shed light on a 'neglected' disease.

A colpo d'occhio

Stato
Attivo ma non reclutante
Fase
NA
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Obiettivo di iscrizione
200
Inizio
06 Jan 2021
Completamento stimato
01 Jul 2027

Di cosa tratta questo studio?

This study is called COLEPT, and it's designed to learn more about a health problem called leptospirosis. This is an infection caused by bacteria that can make people quite unwell. It often spreads from animals to humans, but many people, including doctors, don't know a lot about it. This study aims to change that by gathering detailed information from people who are in hospital with suspected or confirmed leptospirosis.

Over a year, researchers will keep track of how the illness affects people, how their bodies respond to the infection, and any other health information that might be important. The main goal is to understand leptospirosis much better, including its causes, symptoms, and long-term effects. This will help doctors diagnose and treat it more effectively in the future, improving care for patients.

By taking part, you would be helping medical science. The information collected from volunteers in this study can lead to new discoveries and better ways to care for people with leptospirosis around the world. It's an important step in tackling what is currently a 'neglected' disease.

Punti chiave

  • The study looks at people in hospital with suspected or confirmed leptospirosis.
  • It aims to understand this bacterial infection better over a one-year period.
  • Participation involves giving blood and urine samples.
  • No new medications are given as part of the study.
  • Information from the study could lead to better future treatments.
  • Puoi smettere di partecipare in qualsiasi momento.

Chi può essere idoneo?

To be considered for this study, you would need to be in hospital because doctors think you might have leptospirosis, or already know you have it based on tests. Your symptoms must have started within the last three weeks.

You also need to have health insurance, which is a common requirement for many medical studies. Unfortunately, if you or your family (if you're unable to decide yourself, for example, if you're in a coma or intensive care) say no to taking part, then you wouldn't be able to join the study.

Questo studio potrebbe fare al caso tuo?

Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.

  1. Are you currently in hospital because doctors suspect or have confirmed leptospirosis?
  2. Did your symptoms start within the last 21 days (three weeks)?
  3. Do you have health insurance?
  4. Have you (or your family, if you can't decide) agreed to consider participating?
Rispondi a ogni domanda per vedere il tuo risultato.

Cosa comporta la partecipazione?

If you decide to take part in this study, the doctors and nurses will regularly collect blood and urine samples from you while you are in hospital and during follow-up over one year. These samples will be tested straight away and also stored in a special collection called a 'biobank' for future research. You won't be given any new medications or treatments specially for the study; the focus is on gathering information about your illness. The total duration of your participation, meaning how long they will follow your health and collect samples, will be for one year.

Rischi e benefici potenziali

Taking part in this study could help doctors and researchers understand leptospirosis better, which might lead to improved diagnosis and treatment for others in the future. The main risks involve giving blood samples, which might cause a little discomfort, bruising, or, very rarely, an infection. All samples will be taken by trained professionals to minimise any risks. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Luoghi (4)

  • Groupe Hospitalier Est Réunion (GHER)
    Codice postale verificato
    Saint-Benoît, France
  • CHU de La Réunion site Nord
    Codice postale verificato
    Saint-Denis, France
  • Centre Hospitalier Ouest Réunion (CHOR)
    Codice postale verificato
    Saint-Paul, France
  • CHU de La Réunion site Sud (GHSR)
    Codice postale verificato
    Saint-Pierre, France

Domande comuni

Che cos'è la leptospirosi?

It's an infection caused by bacteria, often spread from animals, that can make people very unwell.

Perché questo studio è importante?

It aims to learn much more about leptospirosis, which is not well understood, to help improve care for future patients.

Will I get new medicine in this study?

No, you won't be given any special study medications. The study focuses on collecting information and samples.

Per quanto tempo sarò nello studio?

You will be followed by the study for a total of one year.

Posso abbandonare lo studio se cambio idea?

Yes, you can choose to leave the study at any point without it affecting your medical care.

Come saperne di più

Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.

Discussione

Discussione della comunità

Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.